Completed
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
NCT01103089
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Amsterdam, Netherlands
- Research Site Apeldoorn, Netherlands
- Research Site Groningen, Netherlands
- Research Site Helmond, Netherlands